艾迪注射液和槐耳配合介入疗法治疗原发性肝癌

目的 观察艾迪注射液和槐耳颗粒配合介入疗法治疗原发性肝癌的临床疗效及毒副作用.方法 将43例原发性肝癌患者随机分为两组,即治疗组22例（艾迪注射液和槐耳颗粒联合肝癌介入治疗）与对照组21例（单纯肝癌介入治疗）,对两组患者近期疗效、毒副作用进行比较.结果 治疗组有效率59.1%,对照组为33.3%,差异有统计学意义（P＜0.01）;治疗组临床获益率（86.4%）高于对照组（71.4%）,差异也有统计学意义21例（P＜0.05）;治疗组患者生活质量明显提高,T细胞及NK细胞活性均有提高,且均优于对照组（均P＜0.05）;治疗组胃肠反应发生率和白细胞下降率均较对照组低（均P＜0.05）.结论 艾迪注射液和槐耳颗粒配合介入疗法治疗原发性肝癌能提高近期疗效,改善患者免疫活性,提高生活质量,且不良反应小.

Observation on the clinical effiect of Aidi injection and Huaier particles combined with interventional therapy for primary liver cancer

Objective To observe the clinical effiect and toxicity of Aidi injection and Huaier particles combined with interventional therapy for primary liver cancer patients.Methods 43 paients with primary liver cancer were randomly divided into two groups:the treatment group 22 cases(Aidi injection and Huaier particles combined with interventional therapy to the primary liver cancer)and the control group 21 cases(treated only with intervention therapy of liver cancer).The recent efficiency and toxicity of the two groups were compared.Results The effective rate of the treatment group was 59.1%,and in control group was 33.3%,and the differences was significant(P＜0.01).In the treatment group,clinical benefit rate was 86.4%higher than than of the control group(71.4%),and the difference was significant(P＜0.05);The treatment group significantly improved the quality of life of patients,T cell and NK cell activity were improved,and better than the control group(P＜0.05).The incidence of gastrointestinal reactions and neutropenia rate in treatment group was lower than the control group(all P＜0.05).Conclusion Aidi injection and Huaier Granule interventional therapy could improve the curative effect of primary liver cancer、the immune activity、quality of patients life,and the adverse effects.